Articles From: OpenTable Diners Can Now Settle the Check with Apple Pay to Opexa Therapeutics to Present at September Conferences


Integration with Apple Pay makes OpenTable mobile payment experience frictionless for diners SAN FRANCISCO , Oct.
Sign-up for OpenTable Diners Can Now Settle the Check with Apple Pay investment picks
Integration with Apple Pay makes OpenTable payment experience even more intuitive and seamless SAN FRANCISCO , Sept 9, 2014 /PRNewswire/ -- OpenTable , the world's leading provider of online restaurant reservations and part of The Priceline Group (NASDAQ: PCLN) , today announced that it has integrated its "Pay with OpenTable" feature with Apple Pay and will introduce it to diners this fall.
Sign-up for OpenTable Integrates with Apple Pay to Enable Convenient Mobile Payments for Restaurant Goers investment picks
Pay with OpenTable launches in the DC Metro Area and will be available in a total of 20 U.S. cities before year end SAN FRANCISCO , Oct.
Sign-up for OpenTable Mobile Payments March into Washington investment picks
Newer Eateries Rule the List; Winning Restaurants Span 29 States with California, Oregon, and Pennsylvania Restaurants Making the Strongest Showing and the Cities of Portland and Philadelphia Boasting the Most Honorees SAN FRANCISCO , Sept.
Sign-up for OpenTable Restaurant Reviews Reveal the Top 100 Fit for Foodies Restaurants in America investment picks
Winning Wine List Restaurants Cover 28 States; California, Ohio, Illinois, and Maryland Garner Most Honorees SAN FRANCISCO , Oct.
Sign-up for OpenTable Restaurant Reviews Reveal the Top 100 Wine Lists in America investment picks
2014/10/6
OpenText settles patent infringement claims against Alfresco Software, Ltd; parties agreed to patent license and court dismissal WATERLOO, Ontario , Oct.
Sign-up for OpenText and Alfresco Reach Agreement to Settle Patent Dispute investment picks
2014/9/26
WATERLOO, Ontario, Sept.
Sign-up for OpenText Announces Voting Results for Election of Directors investment picks
2014/8/27
WATERLOO, Ontario , Aug.
Sign-up for OpenText CEO Mark J. Barrenechea to Present at Upcoming Investor Conferences investment picks
eDOCS DM 10 Improves Collaboration, Organization and Control for Case Information WATERLOO, Ontario , Aug.
Sign-up for OpenText Launches Next Version of Document Management to Simplify Content Exchange for the Legal Industry investment picks
WATERLOO, Ontario , Oct.
Sign-up for OpenText Named a Leader in Gartner's Magic Quadrant for Enterprise Content Management investment picks
OpenText Named a Leader in Gartner's Magic Quadrant for Enterprise Content Management Canada NewsWire WATERLOO, Ontario , Oct.
Sign-up for OpenText Named a Leader in Gartner's Magic Quadrant for Enterprise Content Management investment picks
OpenText Named One of Canada's Top 100 Employers for the Fourth Consecutive Year Canada NewsWire WATERLOO, Ontario , Nov.
Sign-up for OpenText Named One of Canada's Top 100 Employers for the Fourth Consecutive Year investment picks
WATERLOO, Ontario , Nov.
Sign-up for OpenText Named One of Canada's Top 100 Employers for the Fourth Consecutive Year investment picks
GS1 Hong Kong's ezTRADE Runs on OpenText Trading Grid Platform to Provide Region's Enterprises Access to the World's Largest Integration Cloud HONG KONG , Aug.
Sign-up for OpenText Powers Hong Kong's Leading EDI Platform investment picks
WATERLOO, Ontario , Oct.
Sign-up for OpenText Reports First Quarter Fiscal Year 2015 Financial Results investment picks
OpenText Reports First Quarter Fiscal Year 2015 Financial Results Canada NewsWire WATERLOO, Ontario , Oct.
Sign-up for OpenText Reports First Quarter Fiscal Year 2015 Financial Results investment picks
2014/10/10
WATERLOO, Ontario , Oct.
Sign-up for OpenText to Report First Quarter Fiscal Year 2015 Financial Results on Wednesday, October 22, 2014 investment picks
2014/10/2
USA TODAY launches new 3D Bingo game app as first major entry into casual games market SAN FRANCISCO , Oct.
Sign-up for OpenWager Partners with USA TODAY to Unveil USA TODAY Bingo Cruise investment picks
2014/10/29
ESCONDIDO, Calif.
Sign-up for Operating Results For Third Quarter And First Nine Months Of 2014 Announced By Realty Income investment picks
Operation Homefront and Meritage Homes Corporation (NYSE: MTH) have selected three military families to receive newly-built mortgage-free homes.
Sign-up for Operation Homefront Selects Three Veterans for Mortgage-Free Homes from Meritage Homes investment picks
2014/8/21
JOHANNESBURG , August 21, 2014 /PRNewswire/ -- Gold Fields Limited (Gold Fields) (JSE, NYSE, NASDAQ Dubai: GFI) today announced normalised earnings from continuing operations for the June 2014 quarter of US$25 million compared with US$21 million for the March 2014 quarter and losses of US$36 million for the June 2013 quarter.
Sign-up for Operational Performance Leads to Cash Generation, Dividend Payments and Further Debt Reduction investment picks
2014/9/15
BERWICK, Pa.
Sign-up for Operators Reconnect Unit 2 at Susquehanna Nuclear Power Plant investment picks
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and Neuromyelitis Optica (NMO), today announced the expansion of its intellectual property portfolio.
Sign-up for Opexa Strengthens Patent Portfolio with Expansion Into B-cell Diseases and Announces Allowance of 98th T-cell Patent investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and Neuromyelitis Optica (NMO), today announced that it will hold an Analyst and Investor Event in New York City, New York on Thursday, October 9, 2014.
Sign-up for Opexa Therapeutics Announces Analyst and Investor Event investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced that the Company will report financial results for the three months ended September 30, 2014 after the close of trading on Thursday, November 6th.
Sign-up for Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2014 Financial Results investment picks
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biotechnology company developing Tcelna ® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of Multiple Sclerosis (MS), today reported financial results for the second quarter ended June 30, 2014 and provided an overview of the Company’s recent corporate developments.
Sign-up for Opexa Therapeutics Reports Second Quarter 2014 Financial Results and Provides Corporate Update investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and Neuromyelitis Optica (NMO), today reported financial results for the third quarter ended September 30, 2014 and provided an overview of the Company’s recent corporate developments.
Sign-up for Opexa Therapeutics Reports Third Quarter 2014 Financial Results and Provides Corporate Update investment picks
Opexa Therapeutics, Inc. (NASDAQ:OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and neuromyelitis optica (NMO), today announced its partnership with the National Multiple Sclerosis Society, Lone Star Chapter, as a sponsor of the nonprofit’s annual Houston area Walk MS fundraisers for the fourth consecutive year.
Sign-up for Opexa Therapeutics Supports National Multiple Sclerosis Society and Walk MS investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biopharmaceutical company developing personalized immunotherapies for autoimmune disorders, including multiple sclerosis (MS) and Neuromyelitis Optica (NMO), today announced that Neil K.
Sign-up for Opexa Therapeutics to Present at Cleveland Clinic’s 12th Annual Medical Innovation Summit investment picks
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a biotechnology company developing Tcelna ® (imilecleucel-T), a novel T-cell immunotherapy for the treatment of multiple sclerosis (MS), today announced that Neil K.
Sign-up for Opexa Therapeutics to Present at September Conferences investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: OpenTable Diners Can Now Settle the Check with Apple Pay to Opexa Therapeutics to Present at September Conferences
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent